$EKSO
EKSO BIONICS HOLDINGS, INC.

2022 Q4 Form 10-Q Financial Statement

#000154908422000071 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $3.551M $3.329M $3.049M
YoY Change -12.88% 9.18% 5.25%
Cost Of Revenue $1.873M $1.643M $1.242M
YoY Change 12.76% 32.29% 14.58%
Gross Profit $1.678M $1.686M $1.807M
YoY Change -30.52% -6.7% -0.33%
Gross Profit Margin 47.25% 50.65% 59.27%
Selling, General & Admin $5.343M $4.404M $3.978M
YoY Change -13.11% 10.71% 15.44%
% of Gross Profit 318.41% 261.21% 220.14%
Research & Development $771.0K $936.0K $618.0K
YoY Change -5.75% 51.46% 3.17%
% of Gross Profit 45.95% 55.52% 34.2%
Depreciation & Amortization $255.0K $170.0K $158.0K
YoY Change 96.15% 7.59% 5.33%
% of Gross Profit 15.2% 10.08% 8.74%
Operating Expenses $6.114M $5.340M $4.596M
YoY Change -12.24% 16.19% 8.55%
Operating Profit -$4.436M -$3.654M -$2.789M
YoY Change -2.55% 31.01% 15.2%
Interest Expense $983.0K $34.00K $24.00K
YoY Change -516.53% 41.67% 4.35%
% of Operating Profit
Other Income/Expense, Net $275.0K -$650.0K $831.0K
YoY Change -85.71% -178.22% -82.95%
Pretax Income -$3.178M -$4.304M -$1.958M
YoY Change 11.0% 119.82% -179.92%
Income Tax
% Of Pretax Income
Net Earnings -$3.178M -$4.304M -$1.958M
YoY Change 11.0% 119.82% -179.85%
Net Earnings / Revenue -89.5% -129.29% -64.22%
Basic Earnings Per Share -$0.33 -$0.15
Diluted Earnings Per Share -$0.24 -$0.33 -$0.17
COMMON SHARES
Basic Shares Outstanding 13.14M shares 13.03M shares 12.66M shares
Diluted Shares Outstanding 13.07M shares 12.71M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.53M $29.18M $43.44M
YoY Change -49.2% -32.83% 198.55%
Cash & Equivalents $20.53M $29.18M $43.44M
Short-Term Investments
Other Short-Term Assets $700.0K $668.0K $788.0K
YoY Change 44.33% -15.23% 112.97%
Inventory $5.187M $3.508M $1.751M
Prepaid Expenses
Receivables $4.625M $3.398M $3.121M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $31.04M $36.75M $49.10M
YoY Change -35.06% -25.14% 127.85%
LONG-TERM ASSETS
Property, Plant & Equipment $2.680M $959.0K $1.172M
YoY Change 170.43% -18.17% 13.46%
Goodwill $431.0K
YoY Change
Intangibles $5.217M
YoY Change
Long-Term Investments
YoY Change
Other Assets $231.0K $224.0K $125.0K
YoY Change 40.85% 79.2% 5.93%
Total Long-Term Assets $9.866M $2.557M $1.634M
YoY Change 619.62% 56.49% -15.64%
TOTAL ASSETS
Total Short-Term Assets $31.04M $36.75M $49.10M
Total Long-Term Assets $9.866M $2.557M $1.634M
Total Assets $40.90M $39.31M $50.73M
YoY Change -16.81% -22.51% 116.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.151M $2.387M $1.308M
YoY Change 1.42% 82.49% -27.85%
Accrued Expenses $2.278M $2.172M $1.704M
YoY Change -0.91% 27.46% 8.81%
Deferred Revenue $1.121M $1.059M $1.291M
YoY Change -8.11% -17.97% -10.84%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.310M $1.996M $0.00
YoY Change
Total Short-Term Liabilities $9.201M $7.858M $4.675M
YoY Change 34.22% 68.09% -10.66%
LONG-TERM LIABILITIES
Long-Term Debt $3.767M $0.00 $1.992M
YoY Change 89.01% -100.0% -35.32%
Other Long-Term Liabilities $141.0K $101.0K $54.00K
YoY Change 90.54% 87.04% 80.0%
Total Long-Term Liabilities $141.0K $101.0K $2.046M
YoY Change -93.18% -95.06% 6720.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.201M $7.858M $4.675M
Total Long-Term Liabilities $141.0K $101.0K $2.046M
Total Liabilities $15.46M $10.70M $11.67M
YoY Change 29.41% -8.35% -22.63%
SHAREHOLDERS EQUITY
Retained Earnings -$223.9M -$220.8M -$206.0M
YoY Change 7.22% 7.17% 5.57%
Common Stock $13.00K $13.00K $13.00K
YoY Change 0.0% 0.0% 62.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.44M $28.61M $39.06M
YoY Change
Total Liabilities & Shareholders Equity $40.90M $39.31M $50.73M
YoY Change -16.81% -22.51% 116.01%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$3.178M -$4.304M -$1.958M
YoY Change 11.0% 119.82% -179.85%
Depreciation, Depletion And Amortization $255.0K $170.0K $158.0K
YoY Change 96.15% 7.59% 5.33%
Cash From Operating Activities -$3.644M -$2.590M -$2.475M
YoY Change 18.5% 4.65% 94.88%
INVESTING ACTIVITIES
Capital Expenditures $53.00K -$141.0K -$60.00K
YoY Change 5200.0% 135.0%
Acquisitions
YoY Change
Other Investing Activities -$4.981M
YoY Change
Cash From Investing Activities -$5.034M -$141.0K -$60.00K
YoY Change -503500.0% 135.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -3.644M -2.590M -2.475M
Cash From Investing Activities -5.034M -141.0K -60.00K
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -8.678M -2.731M -2.535M
YoY Change 182.3% 7.73% -299.61%
FREE CASH FLOW
Cash From Operating Activities -$3.644M -$2.590M -$2.475M
Capital Expenditures $53.00K -$141.0K -$60.00K
Free Cash Flow -$3.697M -$2.449M -$2.415M
YoY Change 20.19% 1.41% 90.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001549084
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37854
dei Entity Registrant Name
EntityRegistrantName
Ekso Bionics Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0367049
dei Entity Address Address Line1
EntityAddressAddressLine1
101 Glacier Point
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
San Rafael
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94901
dei City Area Code
CityAreaCode
510
dei Local Phone Number
LocalPhoneNumber
984-1761
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
EKSO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13142418 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29180000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40406000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
28000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3398000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4662000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
3508000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
2242000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
668000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
485000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
36754000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
47795000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
959000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
991000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1374000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
216000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
224000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
164000 usd
CY2022Q3 us-gaap Assets
Assets
39311000 usd
CY2021Q4 us-gaap Assets
Assets
49166000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2387000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3107000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2172000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2299000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1059000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1220000 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1996000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
244000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
229000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7858000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6855000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1032000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1475000 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1993000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1167000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
539000 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1550000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
101000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
74000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
10697000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
11947000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13127000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13127000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12693000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12693000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
13000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
13000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
247884000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
246090000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1486000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-220769000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-208867000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
28614000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
37219000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39311000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49166000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3329000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3049000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9361000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7170000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1643000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1242000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4825000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2836000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1686000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
1807000 usd
us-gaap Gross Profit
GrossProfit
4536000 usd
us-gaap Gross Profit
GrossProfit
4334000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1742000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1685000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5212000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5265000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
936000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
618000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2855000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1930000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2662000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2293000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7589000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6415000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
5340000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
4596000 usd
us-gaap Operating Expenses
OperatingExpenses
15656000 usd
us-gaap Operating Expenses
OperatingExpenses
13610000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3654000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2789000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11120000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9276000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
34000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
24000 usd
us-gaap Interest Expense
InterestExpense
90000 usd
us-gaap Interest Expense
InterestExpense
77000 usd
CY2022Q3 ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
112000 usd
CY2021Q3 ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
1125000 usd
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
1011000 usd
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
2011000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1099000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-732000 usd
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-268000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1704000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-640000 usd
CY2022Q3 ekso Other Income Expense
OtherIncomeExpense
4000 usd
CY2021Q3 ekso Other Income Expense
OtherIncomeExpense
-2000 usd
ekso Other Income Expense
OtherIncomeExpense
1000 usd
ekso Other Income Expense
OtherIncomeExpense
-18000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-650000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
831000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-782000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2375000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4304000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1958000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11902000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6901000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
652000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
261000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1503000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
601000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3652000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1697000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10399000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6300000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13071000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12661000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12896000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12029000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13071000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12710000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12896000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12133000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
37219000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4620000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
176000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
499000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
212000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
33486000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2978000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
582000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
639000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
31729000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4304000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
537000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
652000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
28614000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4434000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3670000 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35360000 usd
CY2021Q1 ekso Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
3878000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
152000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
356000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
465000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
40975000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1273000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
519000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-125000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
40096000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1958000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
663000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
261000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
39062000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11902000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6901000 usd
us-gaap Depreciation
Depreciation
632000 usd
us-gaap Depreciation
Depreciation
782000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-11000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
48000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1099000 usd
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
1011000 usd
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
2011000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1618000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1538000 usd
ekso Common Stock Contribution
CommonStockContribution
147000 usd
ekso Common Stock Contribution
CommonStockContribution
141000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1704000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-640000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1044000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1477000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
171000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
277000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
251000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-704000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-189000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-270000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-70000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-537000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-528000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11044000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8081000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
141000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
60000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-141000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
37295000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1417000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38712000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-41000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11226000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30577000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40406000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12862000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29180000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43439000 usd
us-gaap Interest Paid Net
InterestPaidNet
88000 usd
us-gaap Interest Paid Net
InterestPaidNet
69000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
14000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
ekso Fair Value Of Warrants Issued Upon Equity Financing
FairValueOfWarrantsIssuedUponEquityFinancing
0 usd
ekso Fair Value Of Warrants Issued Upon Equity Financing
FairValueOfWarrantsIssuedUponEquityFinancing
1936000 usd
us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
0 usd
us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
2461000 usd
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
192000 usd
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
387000 usd
ekso Operating Leases Liability Right Of Use Asset Initial Recognition
OperatingLeasesLiabilityRightOfUseAssetInitialRecognition
1459000 usd
ekso Operating Leases Liability Right Of Use Asset Initial Recognition
OperatingLeasesLiabilityRightOfUseAssetInitialRecognition
0 usd
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
176000 usd
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
152000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-220769000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11044000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29180000 usd
CY2022Q3 ekso Debt Covenant Covenant Compliance Unrestricted Cash
DebtCovenantCovenantComplianceUnrestrictedCash
2000000 usd
ekso Unrestricted Cash
UnrestrictedCash
27180000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2022, the Company reclassified the amortization of operating lease right-of-use assets in its condensed consolidated statements of cash flows. Amounts amortized related to operating lease right-of-use assets </span></div>have been reclassified to "Depreciation and amortization" from "Prepaid expenses and other assets, current and noncurrent" as applicable. Accordingly, prior period amounts have been reclassified to conform to the current period presentation, in all material respects. These reclassifications did not affect changes in cash flow used in operating activities or net (decrease) in cash for the nine months ended September 30, 2021
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to, revenue recognition, deferred revenue, the valuation of warrants and employee equity awards, future warranty costs, accounting for leases, useful lives assigned to long-lived assets, valuation of inventory, realizability of deferred tax assets, and contingencies. Actual results could differ from those estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains cash accounts in excess of federally insured limits. However, the Company believes it is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. The Company extends credit to customers in the normal course of business. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the condensed consolidated financial statements. The Company does not require collateral from its customers to secure accounts receivable.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are derived from the sale of products shipped and services performed for customers primarily located in the U.S., Europe, Asia, and Australia. Invoices are aged based on contractual terms with the customer. The Company reviews accounts receivable for collectability and provides an allowance for potential credit losses. The Company has not experienced material losses related to accounts receivable as of September 30, 2022 and December 31, 2021. Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar. The Company does not enter into any foreign currency hedging agreements and is susceptible to gains and losses from foreign currency fluctuations. To date, the Company has not experienced significant gains or losses upon collecting receivables denominated in a foreign currency.</span></div>
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1503000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
601000 usd
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
1011000 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2845000 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2061000 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
373000 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
145000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
290000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
36000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
3508000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
2242000 usd
CY2022Q3 ekso Contract With Customer Liability Extended Maintenance And Support
ContractWithCustomerLiabilityExtendedMaintenanceAndSupport
2056000 usd
CY2021Q4 ekso Contract With Customer Liability Extended Maintenance And Support
ContractWithCustomerLiabilityExtendedMaintenanceAndSupport
2349000 usd
CY2022Q3 ekso Contract With Customer Liability Royalties
ContractWithCustomerLiabilityRoyalties
0 usd
CY2021Q4 ekso Contract With Customer Liability Royalties
ContractWithCustomerLiabilityRoyalties
280000 usd
CY2022Q3 ekso Contract With Customer Liability Devices And Advances
ContractWithCustomerLiabilityDevicesAndAdvances
35000 usd
CY2021Q4 ekso Contract With Customer Liability Devices And Advances
ContractWithCustomerLiabilityDevicesAndAdvances
66000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2091000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2695000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1059000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1220000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1032000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1475000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2695000 usd
ekso Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
1014000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1618000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2091000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2091000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
375000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
897000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
819000 usd
CY2022Q3 ekso Contract With Customer Liability Non Cancellable Backlog
ContractWithCustomerLiabilityNonCancellableBacklog
2527000 usd
CY2021Q4 ekso Contract With Customer Liability Royalties
ContractWithCustomerLiabilityRoyalties
280000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3329000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9361000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3049000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7170000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
189000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2000000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1822000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2015000 usd
CY2022Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
224000 usd
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
195000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
126000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
89000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2172000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2299000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29180000 usd
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2000000 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
4000 usd
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
168000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1411000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
1996000 usd
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1996000 usd
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
1996000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
13000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
403000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
415000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
399000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
349000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1579000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y11M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.054
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
130000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
455000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
395000 usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13127000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13127000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12693000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12693000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1240000 shares
ekso Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
0 shares
ekso Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1240000 shares
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1417000 usd
CY2022Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
50000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
537000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
663000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1618000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1539000 usd
us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
68000 shares
us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
26000 shares
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
176000 usd
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
152000 usd
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
ekso Common Stock Contribution
CommonStockContribution
147000 usd
ekso Common Stock Contribution
CommonStockContribution
141000 usd
us-gaap Longterm Purchase Commitment Period
LongtermPurchaseCommitmentPeriod
P1Y
CY2022Q3 us-gaap Contractual Obligation
ContractualObligation
3203000 usd
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
1446000 usd
CY2022Q3 ekso Lessee Operating Lease Lease Not Yet Commenced
LesseeOperatingLeaseLeaseNotYetCommenced
1579000 usd
CY2022Q3 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P49M
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4304000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1958000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11902000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6901000 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
158000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
643000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-4304000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2116000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11902000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7544000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13071000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12661000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12896000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12029000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
49000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
104000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13071000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12710000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12896000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12133000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2460000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2142000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2460000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1976000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3329000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1643000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1686000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3049000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1242000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
1807000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9361000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4825000 usd
us-gaap Gross Profit
GrossProfit
4536000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7170000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2836000 usd
us-gaap Gross Profit
GrossProfit
4334000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3329000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3049000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9361000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7170000 usd

Files In Submission

Name View Source Status
ekso-20220930_def.xml Edgar Link unprocessable
0001549084-22-000071-index-headers.html Edgar Link pending
0001549084-22-000071-index.html Edgar Link pending
0001549084-22-000071.txt Edgar Link pending
0001549084-22-000071-xbrl.zip Edgar Link pending
ekso-20220930.htm Edgar Link pending
ekso-20220930.xsd Edgar Link pending
ekso-9302022xex311.htm Edgar Link pending
ekso-9302022xex312.htm Edgar Link pending
ekso-9302022xex321.htm Edgar Link pending
ekso-20220930_cal.xml Edgar Link unprocessable
ekso-20220930_lab.xml Edgar Link unprocessable
ekso-20220930_pre.xml Edgar Link unprocessable
ekso-20220930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
ekso-9302022xex322.htm Edgar Link pending
ex-101.htm Edgar Link pending
ex-101001.jpg Edgar Link pending
ex-101002.jpg Edgar Link pending
ex-101003.jpg Edgar Link pending
ex-101004.jpg Edgar Link pending
ex-101005.jpg Edgar Link pending
ex-101006.jpg Edgar Link pending
ex-101007.jpg Edgar Link pending
ex-101008.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending